We have a lead compound that we really want to explore, because it does, in fact, interact with a viral protein in the way that we predicted it to interact, so it has a chance of inhibiting viral entry into a host cell, says Brad Pentelute, an MIT associate professor of chemistry, who is leading the research team
BPC-157 has been studied across an unusually broad range of tissue repair contexts
B12+MIC therapy requires approval from a licensed physician
BPC-157 has been discussed by the FDA in the context of bulk drug substances that may present significant safety risks, and TB-500 is generally promoted in research-peptide settings rather than as an FDA-approved therapeutic product
Bespreekt de darm-hersenverbinding via BPC-157, inclusief serotonerge en dopaminerge effecten in diermodellen